Carmon Lior, Bachar Yoav, Babiev Amit S, Hazn Itai, Hershkovitz Eli, Shaki David, Loewenthal Neta, Haim Alon, Hazan Guy
Pediatric Endocrinology Unit, Soroka University Medical Center, Beer-Sheva 8457108, Israel.
Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 8457108, Israel.
World J Diabetes. 2025 Aug 15;16(8):108724. doi: 10.4239/wjd.v16.i8.108724.
Type 1 diabetes mellitus (T1DM) is an autoimmune disease with a multifactorial pathogenesis. Viral infections have been proposed as contributing triggers, supported by the disease's seasonal pattern, which typically shows higher incidence in autumn and winter. The coronavirus disease 2019 (COVID-19) pandemic and associated lockdowns created a unique context to examine the incidence and seasonality of T1DM during a period characterized by reduced circulation of common viral infections.
To investigate the incidence and seasonality of T1DM before and during COVID-19 pandemic in relation to global viral infection rates.
This population-based retrospective study utilized a nationwide computerized database. Extracted data included the number of new T1DM cases over the 8 years preceding and during the COVID-19 pandemic, demographic characteristics of affected individuals, and nationwide respiratory virus polymerase chain reaction data from weekly nasal wash sample collections.
A total of 2176 patients were diagnosed with new-onset T1DM during the pre-pandemic period, compared to 348 cases during the pandemic. In the same periods, 33727 respiratory virus-positive polymerase chain reaction results from nasal wash samples were recorded pre-pandemic, compared to 2603 during the pandemic. Additionally, 363399 positive COVID-19 cases were reported during the pandemic period. Seasonality analysis revealed a higher rate of new-onset T1DM cases and a weaker seasonal pattern during the pandemic. Trend analysis showed a consistent increase in T1DM incidence prior to COVID-19, with a more variable trend observed during the pandemic. Correlation analysis between T1DM incidence and respiratory viruses demonstrated a weak correlation between T1DM incidence and a few respiratory viruses.
The observed increase in new-onset T1DM cases and the disruption of its typical seasonal pattern during the COVID-19 pandemic suggest a potential association between respiratory virus exposure and the development of T1DM.
1型糖尿病(T1DM)是一种发病机制多因素的自身免疫性疾病。病毒感染被认为是促发因素,疾病的季节性模式支持了这一观点,其发病率通常在秋季和冬季较高。2019冠状病毒病(COVID-19)大流行及相关封锁措施创造了一个独特的环境,可用于研究在常见病毒感染传播减少的时期T1DM的发病率和季节性。
调查COVID-19大流行之前和期间T1DM的发病率和季节性与全球病毒感染率的关系。
这项基于人群的回顾性研究利用了全国性的计算机数据库。提取的数据包括COVID-19大流行之前和期间8年的新T1DM病例数、受影响个体的人口统计学特征,以及每周鼻洗样本采集的全国呼吸道病毒聚合酶链反应数据。
在大流行前时期,共有2176例患者被诊断为新发T1DM,而在大流行期间为348例。在同一时期,大流行前鼻洗样本的33727份呼吸道病毒阳性聚合酶链反应结果被记录,而大流行期间为2603份。此外,在大流行期间报告了363399例COVID-19阳性病例。季节性分析显示,大流行期间新发T1DM病例率较高,季节性模式较弱。趋势分析显示,COVID-19之前T1DM发病率持续上升,大流行期间趋势变化更大。T1DM发病率与呼吸道病毒之间的相关性分析表明,T1DM发病率与少数呼吸道病毒之间存在弱相关性。
在COVID-19大流行期间观察到的新发T1DM病例增加及其典型季节性模式的破坏表明,呼吸道病毒暴露与T1DM的发生之间可能存在关联。